The system, known as CoMPaSS (Complete Medication and Patient Support System), will be installed at all Lloydspharmacy branches in a rollout programme scheduled for completion next year. CoMPaSS will streamline the 110 million prescriptions that the company dispenses every year and provide a basis for many additional benefits for patients, pharmacists and the NHS.
Lloydspharmacy has also awarded a contract to Capgemini to manage and support the IT that underpins the new system on a five-year outsourcing basis.
The CoMPaSS system has been designed to support the greatly expanded role of pharmacies in UK healthcare policy arising from recent Department of Health initiatives and to enable the company’s pharmacists to work more closely with general practitioners, NHS hospitals and primary care teams.
Patients will benefit from the expanding range of services that are supported and enabled by the new system. These include private consultations with pharmacists, drug utilisation reviews, management of chronic conditions such as asthma, diabetes and hypertension, blood glucose monitoring, blood pressure testing, advice on healthy lifestyles, and treatment for a wide range of minor ailments. The new system also supports extensive patient records protected by high levels of security, more efficient management of repeat prescriptions and dispensing to care homes.
The system has been designed to provide a platform upon which future NHS initiatives, such as electronic prescribing and claiming, can be built.
Business benefits of the new system include centralised data, improved management information, better cost control, automated inventory management with automatic reordering and replenishment facilities.
Roy Maddison, CoMPaSS Programme Manager at Lloydspharmacy, said: ‘The role of pharmacies in UK healthcare is undergoing large-scale change, and in this new environment only those able to offer new facilities and new efficiencies will succeed. The major investment we are making in new dispensing technology reflects our determination to maintain and enhance our position of leadership in this key area of primary healthcare.’
Design work on the new system was centred on a Capgemini development facility in Birmingham. Capgemini achieved highly cost-effective delivery by applying its RightshoreTM approach to the project, with much of the work carried out at its development centre in Mumbai, India. The Capgemini solution incorporates a number of leading-edge technologies including components from Oracle, Java and Sybase.
Capgemini, one of the world’s foremost providers of Consulting, Technology and Outsourcing services, has a unique way of working with its clients, which it calls the Collaborative Business Experience. Through commitment to mutual success and the achievement of tangible value, Capgemini helps businesses implement growth strategies, leverage technology, and thrive through the power of collaboration. Capgemini employs approximately 61,000 people worldwide and reported 2005 global revenues of 6,954 million euros.
Lloydspharmacy is the trading name of Lloyds Pharmacy Limited, which in turn is a wholly owned subsidiary of Celesio AG (previously called GEHE AG), the largest pharmaceutical wholesaler in Europe. Celesio AG purchased AAH plc (the UK’s leading pharmaceutical wholesaler) in 1995, and then in 1997, acquired Lloyds Chemists PLC, which at the time had 902 pharmacies. Together with AAH’s 350 strong Hills Pharmacy network, this took the combined group to over 1250 pharmacies. This has now grown to over 1520 pharmacies within the UK.